These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15574466)

  • 21. Impoverishment of spontaneous language and the prediction of Alzheimer's disease.
    Venneri A; Forbes-Mckay KE; Shanks MF
    Brain; 2005 Apr; 128(Pt 4):E27. PubMed ID: 15788549
    [No Abstract]   [Full Text] [Related]  

  • 22. Detecting subtle spontaneous language decline in early Alzheimer's disease with a picture description task.
    Forbes-McKay KE; Venneri A
    Neurol Sci; 2005 Oct; 26(4):243-54. PubMed ID: 16193251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease.
    Weintraub D; Dietz N; Duda JE; Wolk DA; Doshi J; Xie SX; Davatzikos C; Clark CM; Siderowf A
    Brain; 2012 Jan; 135(Pt 1):170-80. PubMed ID: 22108576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discourse macrolinguistic impairment as a marker of linguistic and extralinguistic functions decline in early Alzheimer's disease.
    Pistono A; Jucla M; Bézy C; Lemesle B; Le Men J; Pariente J
    Int J Lang Commun Disord; 2019 May; 54(3):390-400. PubMed ID: 30444044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tracking discourse complexity preceding Alzheimer's disease diagnosis: a case study comparing the press conferences of Presidents Ronald Reagan and George Herbert Walker Bush.
    Berisha V; Wang S; LaCross A; Liss J
    J Alzheimers Dis; 2015; 45(3):959-63. PubMed ID: 25633673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Arlt S; Buchert R; Spies L; Eichenlaub M; Lehmbeck JT; Jahn H
    Eur Arch Psychiatry Clin Neurosci; 2013 Jun; 263(4):335-44. PubMed ID: 22940716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Introduction. The investigation of lexical semantic representation in Alzheimer's disease.
    Henderson VW
    Brain Lang; 1996 Aug; 54(2):179-83. PubMed ID: 8811951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Data modelling in corpus linguistics: how low may we go?
    van Velzen MH; Nanetti L; de Deyn PP
    Cortex; 2014 Jun; 55():192-201. PubMed ID: 24332294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease.
    Desikan RS; Cabral HJ; Hess CP; Dillon WP; Glastonbury CM; Weiner MW; Schmansky NJ; Greve DN; Salat DH; Buckner RL; Fischl B;
    Brain; 2009 Aug; 132(Pt 8):2048-57. PubMed ID: 19460794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central and peripheral agraphia in Alzheimer's disease: from the case of Auguste D. to a cognitive neuropsychology approach.
    Lambert J; Giffard B; Nore F; de la Sayette V; Pasquier F; Eustache F
    Cortex; 2007 Oct; 43(7):935-51. PubMed ID: 17941351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lexical factors and cerebral regions influencing verbal fluency performance in MCI.
    Clark DG; Wadley VG; Kapur P; DeRamus TP; Singletary B; Nicholas AP; Blanton PD; Lokken K; Deshpande H; Marson D; Deutsch G
    Neuropsychologia; 2014 Feb; 54():98-111. PubMed ID: 24384308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical presentation of Moroccan cases with Alzheimer's disease].
    El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B
    Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease.
    Jack CR; Wiste HJ; Vemuri P; Weigand SD; Senjem ML; Zeng G; Bernstein MA; Gunter JL; Pankratz VS; Aisen PS; Weiner MW; Petersen RC; Shaw LM; Trojanowski JQ; Knopman DS;
    Brain; 2010 Nov; 133(11):3336-48. PubMed ID: 20935035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compensatory mechanisms in higher-educated subjects with Alzheimer's disease: a study of 20 years of cognitive decline.
    Amieva H; Mokri H; Le Goff M; Meillon C; Jacqmin-Gadda H; Foubert-Samier A; Orgogozo JM; Stern Y; Dartigues JF
    Brain; 2014 Apr; 137(Pt 4):1167-75. PubMed ID: 24578544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrophy subtypes in prodromal Alzheimer's disease are associated with cognitive decline.
    Ten Kate M; Dicks E; Visser PJ; van der Flier WM; Teunissen CE; Barkhof F; Scheltens P; Tijms BM;
    Brain; 2018 Dec; 141(12):3443-3456. PubMed ID: 30351346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolution of Writing Impairment in Spanish Patients with Alzheimer's Disease.
    González-Nosti M; Cuetos F; Martínez C
    Curr Alzheimer Res; 2020; 17(9):845-857. PubMed ID: 33280596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lexical acquisition in probable Alzheimer's disease.
    Grossman M; Mickanin J; Onishi K; Robinson KM; D'Esposito M
    Brain Lang; 1997 Dec; 60(3):443-63. PubMed ID: 9398392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
    Yew B; Nation DA;
    Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of time and repeated exposure on famous person knowledge in amnestic mild cognitive impairment and Alzheimer's disease.
    Benoit S; Rouleau I; Langlois R; Dostie V; Kergoat MJ; Joubert S
    Neuropsychology; 2017 Oct; 31(7):697-707. PubMed ID: 28639807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.